HARVARD BIOSCIENCE, INC. Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)
HARVARD BIOSCIENCE, INC. (HBIO) reported Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) of $819.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-07.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation · last filed 2024-03-07
- HARVARD BIOSCIENCE, INC. defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2023 was $819.00K.
- HARVARD BIOSCIENCE, INC. defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2022 was -$2.17M.
- HARVARD BIOSCIENCE, INC. defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2021 was -$179.00K, a 118.49% decline from fiscal 2020.
- HARVARD BIOSCIENCE, INC. defined benefit plan, benefit obligation, foreign currency translation gain (loss) for fiscal 2020 was $968.00K, a 49.61% increase from fiscal 2019.
| Period end | Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|
| 2023-12-31 | $819.00K 10-K · filed 2024-03-07 |
| 2022-12-31 | -$2.17M 10-K · filed 2024-03-07 |
| 2021-12-31 | -$179.00K 10-K · filed 2023-03-09 |
| 2020-12-31 | $968.00K 10-K · filed 2022-03-11 |
| 2019-12-31 | $647.00K 10-K/A · filed 2021-03-17 |
| 2018-12-31 | -$1.11M 10-K · filed 2020-03-16 |
| 2017-12-31 | $1.88M 10-K · filed 2019-03-18 |
| 2016-12-31 | -$3.65M 10-K · filed 2018-03-16 |
| 2015-12-31 | -$918.00K 10-K · filed 2017-03-17 |
| 2014-12-31 | -$1.30M 10-K · filed 2016-04-29 |
| 2013-12-31 | $395.00K 10-K · filed 2015-03-12 |
| 2012-12-31 | $711.00K 10-K · filed 2014-03-14 |
| 2011-12-31 | -$107.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |